Sermorelin + GHRP-6 + GHRP-2 9mg Blend
CAS: 86168-78-7 / 87616-84-0 / 158861-67-7
Sermorelin + GHRP-6 + GHRP-2 9mg Blend by BioPeptides is a research-grade peptide formulation combining a growth hormone–releasing hormone (GHRH) analog with two growth hormone–releasing peptides (GHRPs). The blend is designed for laboratory investigations into growth hormone signaling pathways, receptor cross-talk, and endocrine communication mechanisms. Produced using precision peptide synthesis and analytically verified for stability and purity, this triple-peptide formulation enables reproducible experimental models examining multi-pathway GH signaling.
$255.00
Research Use Only
Research Overview
The Sermorelin + GHRP-6 + GHRP-2 blend is a triple-peptide formulation studied in laboratory environments focused on growth hormone signaling mechanisms.
Researchers examine the combined activity of GHRH receptor signaling and dual ghrelin receptor signaling within endocrine communication systems.
The blend enables investigation of complementary peptide pathways influencing growth hormone regulation.
It contributes to broader research exploring multi-pathway peptide signaling in endocrine and pituitary research models.
Scientific Background
Growth hormone release is regulated by complex signaling pathways involving both GHRH and ghrelin receptor mechanisms.
Sermorelin functions as a synthetic analog of growth hormone–releasing hormone studied for GHRH receptor signaling.
GHRP-6 and GHRP-2 interact with ghrelin (GHS-R) receptors, representing complementary GH-regulating pathways.
Combining these peptides allows researchers to examine signaling synergy, receptor cross-talk, and pathway convergence in controlled research models.
Mechanistic Research Perspective
- GHRH receptor signaling pathway research
- Ghrelin receptor (GHS-R) activation studies
- Multi-pathway growth hormone signaling analysis
- Peptide-receptor interaction dynamics
- Endocrine regulatory pathway investigations
Primary Research Applications
Growth Hormone Signaling Research: Used to investigate GH release mechanisms through combined GHRH and ghrelin receptor activation.
Endocrine Pathway Studies: Researchers analyze peptide-mediated hormonal signaling pathways and pituitary communication systems.
Peptide-Receptor Interaction Research: Applied in laboratory assays examining receptor binding, pathway activation, and signaling specificity.
Comparative GH Peptide Research: Supports comparisons between single-pathway, dual-pathway, and triple-pathway peptide signaling models.
Exploratory Endocrine Research: Used in controlled non-clinical research models examining hormone regulatory signaling.
Molecular Characteristics
- Compound Name: Sermorelin + GHRP-6 + GHRP-2 Blend
- Sermorelin CAS Number: 86168-78-7
- GHRP-6 CAS Number: 87616-84-0
- GHRP-2 CAS Number: 158861-67-7
- Peptide Class: Growth hormone signaling peptides
- Form: Lyophilized peptide powder blend
- Unit Size: 9 mg research blend
Stability Profile and Storage Recommendations
- Store lyophilized peptide blend at −20°C
- Protect from moisture and direct light exposure
- Avoid repeated freeze–thaw cycles
- Reconstitute using sterile laboratory-grade solvent
- Seal vial tightly after each use
Solubility and Preparation Considerations
- Soluble in sterile aqueous laboratory solutions
- Compatible with buffered peptide research systems
- Applicable in endocrine pathway assays
- Suitable for receptor signaling experiments
- Compatible with molecular biology and peptide research protocols
Technical Specifications
product Name
Sermorelin + GHRP-6 + GHRP-2 9mg Blend
brand
BioPeptides
purity
Research-grade analytical quality
form
Lyophilized peptide powder blend
synthesis
Solid-phase peptide synthesis (SPPS)
analytical
Identity and purity verification
molecular Structure
Triple-peptide GH signaling formulation
stability
Stable under −20°C storage conditions
Analytical Validation and Quality Assurance
- Molecular identity verification of all peptide components
- Purity and stability assessment
- Structural integrity testing
- Batch-to-batch consistency validation
- Analytical quality control inspection
Regulatory and Compliance Statement
The Sermorelin + GHRP-6 + GHRP-2 blend supplied by BioPeptides is intended strictly for laboratory research use only. It is not approved for human consumption, veterinary use, therapeutic applications, or medical treatments.
Frequently Asked Questions
The blend is used in laboratory studies examining growth hormone signaling through combined GHRH and ghrelin receptor pathways.
Combining these peptides allows researchers to investigate complementary GH-stimulating mechanisms and pathway synergy.
Yes. It is commonly used in controlled laboratory experiments analyzing receptor activation and endocrine signaling pathways.
The blend is studied in endocrinology research, peptide signaling studies, molecular biology, and exploratory hormone pathway research.
The 9mg research format supports extended experimental protocols while reducing variability between peptide batches.
It should be stored at −20°C and protected from light and moisture.